Cargando…
MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6
BACKGROUND: MicroRNAs (miRNAs) are a large group of negative gene regulators that potentially play a critical role in tumorigenesis. Increasing evidences indicate that miR-145 acts a tumor suppressor in numerous human cancers. However, its role in oral carcinogenesis remains poorly defined. The aim...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680295/ https://www.ncbi.nlm.nih.gov/pubmed/23710609 http://dx.doi.org/10.1186/1475-2867-13-51 |
_version_ | 1782273098315202560 |
---|---|
author | Shao, Yuan Qu, Yiping Dang, Siwen Yao, Bowen Ji, Meiju |
author_facet | Shao, Yuan Qu, Yiping Dang, Siwen Yao, Bowen Ji, Meiju |
author_sort | Shao, Yuan |
collection | PubMed |
description | BACKGROUND: MicroRNAs (miRNAs) are a large group of negative gene regulators that potentially play a critical role in tumorigenesis. Increasing evidences indicate that miR-145 acts a tumor suppressor in numerous human cancers. However, its role in oral carcinogenesis remains poorly defined. The aim of this study is to determine expression levels of miR-145 in oral squamous cell carcinomas (OSCCs) and normal mucosa tissues, and explore its biological functions in OSCCs. METHODS: Reverse transcription quantitative real-time PCR (RT-qPCR) assay was used to evaluate expression levels of miR-145. The biological functions of miR-145 were determined by cell proliferation and colony formation, cell cycle and apoptosis, as well as cell invasion assay. RESULTS: MiR-145 was frequently down-regulated in OSCCs compared with normal mucosa tissues. Restoring miR-145 expression in OSCC cells dramatically suppressed cell proliferation and colony formation, and induced G1 phase arrest and cell apoptosis. Importantly, our data showed that miR-145 downregulated the expression of c-Myc and Cdk6, which have previously been identified as two direct targets of miR-145. CONCLUSIONS: Our data suggest that miR-145 exerts its tumor suppressor function by targeting c-Myc and Cdk6, leading to the inhibition of OSCC cell growth. MiR-145 rescue may thus be a rational for diagnostic and therapeutic applications in OSCC. |
format | Online Article Text |
id | pubmed-3680295 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36802952013-06-13 MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6 Shao, Yuan Qu, Yiping Dang, Siwen Yao, Bowen Ji, Meiju Cancer Cell Int Primary Research BACKGROUND: MicroRNAs (miRNAs) are a large group of negative gene regulators that potentially play a critical role in tumorigenesis. Increasing evidences indicate that miR-145 acts a tumor suppressor in numerous human cancers. However, its role in oral carcinogenesis remains poorly defined. The aim of this study is to determine expression levels of miR-145 in oral squamous cell carcinomas (OSCCs) and normal mucosa tissues, and explore its biological functions in OSCCs. METHODS: Reverse transcription quantitative real-time PCR (RT-qPCR) assay was used to evaluate expression levels of miR-145. The biological functions of miR-145 were determined by cell proliferation and colony formation, cell cycle and apoptosis, as well as cell invasion assay. RESULTS: MiR-145 was frequently down-regulated in OSCCs compared with normal mucosa tissues. Restoring miR-145 expression in OSCC cells dramatically suppressed cell proliferation and colony formation, and induced G1 phase arrest and cell apoptosis. Importantly, our data showed that miR-145 downregulated the expression of c-Myc and Cdk6, which have previously been identified as two direct targets of miR-145. CONCLUSIONS: Our data suggest that miR-145 exerts its tumor suppressor function by targeting c-Myc and Cdk6, leading to the inhibition of OSCC cell growth. MiR-145 rescue may thus be a rational for diagnostic and therapeutic applications in OSCC. BioMed Central 2013-05-28 /pmc/articles/PMC3680295/ /pubmed/23710609 http://dx.doi.org/10.1186/1475-2867-13-51 Text en Copyright © 2013 Shao et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Primary Research Shao, Yuan Qu, Yiping Dang, Siwen Yao, Bowen Ji, Meiju MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6 |
title | MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6 |
title_full | MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6 |
title_fullStr | MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6 |
title_full_unstemmed | MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6 |
title_short | MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6 |
title_sort | mir-145 inhibits oral squamous cell carcinoma (oscc) cell growth by targeting c-myc and cdk6 |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680295/ https://www.ncbi.nlm.nih.gov/pubmed/23710609 http://dx.doi.org/10.1186/1475-2867-13-51 |
work_keys_str_mv | AT shaoyuan mir145inhibitsoralsquamouscellcarcinomaoscccellgrowthbytargetingcmycandcdk6 AT quyiping mir145inhibitsoralsquamouscellcarcinomaoscccellgrowthbytargetingcmycandcdk6 AT dangsiwen mir145inhibitsoralsquamouscellcarcinomaoscccellgrowthbytargetingcmycandcdk6 AT yaobowen mir145inhibitsoralsquamouscellcarcinomaoscccellgrowthbytargetingcmycandcdk6 AT jimeiju mir145inhibitsoralsquamouscellcarcinomaoscccellgrowthbytargetingcmycandcdk6 |